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1. Introduction 
TB is an ancient disease, however, it is still a major health problem in the world (Centers for 
Disease Control and Prevention, 2006). The number of new cases of TB worldwide roughly 
correlates with economic conditions: the highest incidences are seen in those countries with 
the lowest gross national products (countries mainly in Africa, Asia, and Latin America). 
WHO numbers indicate that 8 million people are newly infected and nearly 2 million people 
die of TB every year; translating to one person infected every 4 seconds and one person 
dying every 18 seconds (WHO, 2007).  WHO estimates that by year 2020 up to 36 million 
people will die of TB every year (WHO, 2010). The current TB burden in the world is strictly 
associated to Mycobacterium tuberculosis (M.tb) co-infection with HIV, and the recent 
emergence of practically untreatable extensive-, extremely-, and totally-drug resistant M.tb 
strains (XDR-, XXDR-, and TDR-) in endemic areas. In this context, a person infected with a 
XDR/XXDR M.tb strain currently has a survival rate between 36-50%, however, for people 
co-infected with HIV, their survival rate drops to ~15% with a life span of 16 days upon 
XDR/XXDR M.tb infection (Gandhi et al., 2006). XXDR-M.tb strains are resistant to all first 
and second line of drugs currently available, and TDR-M.tb strains are even resistant to the 
new developed drugs currently in clinical trials (Andrews et al., 2010;Basu et al., 2009; 
Gandhi et al., 2006, 2010). Very little is known about the cell wall composition of 
XDR/XXDR/TDR M.tb strains. The presence of phenolic glycolipids and triglycerides in the 
M.tb cell wall has been directly related to the hypervirulence observed in some strains (Reed 
et al., 2004, 2007). However, in the case of XDR/XXDR/TDR M.tb strains, it still is unknown 
which bacterial and host factors are involved in the induction of the overwhelming host 
immune response generated by these strains.   
Initial interactions between M.tb and the host mark the pathway of infection and the 
subsequent host inflammatory response that defines disease outcome. Many studies have 
been performed analyzing the constitution of the cell wall of M.tb, where structural-
biological function relationships for the majority of the cell wall constituents are still being 
elucidated. The majority of the cell wall of M.tb is comprised of carbohydrates and lipids, 
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and there is increasing evidence that microbial determinants readily exposed to the host 
immune system play critical roles in disease pathogenesis. Recent studies have been focused 
on depicting how M.tb adapts to the host by mimicking its cell envelope to mammalian 
glycoforms. Of particular interest is the fact that some M.tb strains are characterized by the 
presence of mannose-containing biomolecules, whose terminal epitopes closely resemble 
those on host mannoproteins. In this scenario, it is thought that M.tb may use this 
resemblance to the host to its advantage gaining entrance and establishing its particular 
intracellular niche within the host; thus, the initial M.tb-host interface may dictate the 
pathway of infection and the successful outcome of the disease. Many factors are involved 
in this interface. First the constitution of the M.tb cell wall, which is strain dependent. Here 
we will discuss the differences in the cell wall among the widely used laboratory strains 
(M.tb H37Rv and M.tb Erdman) and several relevant M.tb clinical isolates in endemic TB 
areas, including hypervirulent, MDR-, XDR, XXDR- and TDR- M.tb strains. We will discuss 
their cell wall constitution in relation to their infection outcome. Second, we will focus on 
the host cell that acts as a niche, the alveolar macrophage, and we will discuss the innate 
immunofactors present on the host cell that contribute to control or alternatively can favor 
the infection. Importantly, we will introduce our new results in an area frequently bypassed 
in many forums, the host environment and how this may challenge the old dogma of the 
real constitution of the M.tb cell wall during infection. We will discuss the alveolar 
microenvironment that M.tb encounters during infection, and how these may 
determine/contribute to the pathway of infection and disease outcome.  
2. The cell wall of M. tuberculosis and its biological functions 
A great effort has been made by many research groups to depict the M.tb cell wall structure 
and biosynthesis. The main distinctive feature of the M.tb cellular envelope cited in all books 
is the thick and waxy cell wall. This complex structure contributes to the main 
characteristics that distinguish mycobacteria, such as the acid fast staining properties, the 
low permeability of the cell wall, the resistance to harsh environments, and the intrinsic 
resistance to many hydrophobic antibiotics (Brennan & Nikaido, 1995;Jarlier & Nikaido, 
1994). The properties of the cell wall barrier also contribute to the intracellular survival of 
the organism by acting as a direct modulator in the immunological reaction between the 
host and mycobacteria (Barry & Mdluli, 1996;Lederer et al., 1975). M.tb is one of a small 
group of species able to survive inside the phagocytic cells of a host, so it is likely that its cell 
wall has special properties defending the bacterium against host microbicidal processes. 
Within the cell wall of M.tb may lie all of the elements associated with TB, including the 
factors responsible for caseation and other features of hypersensitization, the antigens 
responsible for humoral immunity, the agents of toxicity, and thus, the very antigens 
implicated in protective immunity (Brennan, 1988). A detailed electron microscopy study 
has not yet, however, identified any special features in M.tb compared to other non-
pathogenic mycobacteria. The envelope consists of three distinct parts, the plasma 
membrane, the wall, and around it, the outer material. These parts are involved in providing 
mechanical support and osmotic protection plus transport exchange of ions and molecules 
with the micro-environment(s) surrounding the bacillus during the different stages of 
infection. Here we will discuss M.tb cell wall components in terms of their role in M.tb 
pathogenesis, focusing on the M.tb peripheral lipid layer constituents that are involved in 
M.tb-host cell recognition and pathogenesis. 
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2.1 The plasma membrane 
Defined as a classical bilayer (Silva & Macedo, 1983), the M.tb membrane does, however, 
have some distinctive components, notably the lipoglycoconjugates mannose-capped 
lipoarabinomannan (ManLAM), lipomannan (LM), and phosphatidyl-myo-inositol 
mannosides. Integral membrane proteins embedded in the layers of the cell wall have also 
been described (Brennan & Draper, 1994). Analyses of the proteome of the plasma 
membrane of M.tb suggests that the plasma membrane of M.tb is likely to be rich in proteins 
comprising several essential enzymes, receptors and transporters (Sinha et al., 2002), like 
other prokaryotic cell membranes (Sigler & Hofer, 1997). Bioinformatic analysis of the M.tb 
genome predicts more than 600 ‘putative’ membrane-associated proteins with different 
numbers of transmembrane hydrophobic segments. These proteins undoubtedly play a role 
in the uptake and effects of various metabolites, peptides, drugs and antibiotics. 
Nonetheless, the real location, expression patterns, and function for the majority of these 
transmembrane proteins remain relatively unexplored (Lee et al., 1992;Yokoyama & 
Shimizu, 2002; D.B. Young & Garbe, 1991).  
2.2 The cell wall 
The shape-forming properties of the wall are attributable to the peptidoglycan, whose 
chemical structure in M.tb closely resembles that found in other bacteria. Mainly, the cell 
wall is defined as a skeleton formed by a covalently linked structure of peptidoglycan, with 
a branched-chain polysaccharide, the arabinogalactan, attached by phosphodiester bonds. 
The arabinogalactan distal ends are esterified with high-molecular weight fatty acids, the 
mycolic acids, of sizes and structures unique to mycobacteria. This cell wall skeleton 
receives the name of the mycolyl-arabinogalactan-peptidoglycan complex (mAGP) (Besra et 
al., 1995;Daffe et al., 1990). The wall is constructed of three layers. With conventional staining 
using electron microscopy, their appearance is defined with an inner layer of moderate 
electron density, a wider electron-transparent layer, and an outer electron-opaque layer of 
extremely variable appearance and thickness. The outer opaque layer probably contains the 
outer material. The electron-transparent layer appears to be mycolated arabinogalactan, 
which forms a large part of the wall. Finally, the inner layer is speculated to contain both 
peptidoglycan and arabinogalactan (Draper, 1971). 
There are many models of the mycobacterial cell envelope (Bhamidi et al., 2011;Brennan and 
Besra, 1997;Crick et al., 2003;Dmitriev et al., 2000;Domenech et al., 2001). Interactions of the 
asymmetric plasma membrane, peptidoglycan, and covalent attached arabinogalactan 
together with LAM and PIMs have been speculated, at least some of which are known to be 
associated with the plasma membrane. Mycolic acids are known to be attached to the 
majority of the terminal and penultimate arabinose residues of the arabinogalactan (Barry et 
al., 1998). Since the mycolates possess two hydrocarbon chains of unequal lengths, which 
form an irregular monolayer, it is proposed that these are complemented by two different 
classes of polar lipids with medium (e.g. mycocerosates) and short (e.g. acylglycerols) fatty 
acyl chains, respectively (Barry et al., 1998). There is also evidence for a small number of 
porins in the envelope, presumably within the outer hydrophobic bilayer (Senaratne et al., 
1998; Trias et al., 1992). A recent study had committed efforts to solve the enigma involving 
the spatial organization of the mycobacterial cell envelope. This study compared bacteria 
grown in vivo (i.e. Mycobacterium leprae) vs. grown in vitro (i.e. M.tb) showing that bacilli 
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grown in vivo had a more compact cell envelope with more mycolic acids and more but 
shorter arabinogalactan molecules per peptidoglycan (Bhamidi et al., 2011). This differential 
cell envelope spatial conformation may differentially impact the rearrangement of the outer 
surface exposed cell envelope components that have a critical role in M.tb-host recognition. 
The barrier for the influx of solutes such as nutrients or drugs is associated with the parallel 
alignment of mycolic acids (Liu et al., 1995;Liu et al., 1996). As a consequence, mycobacteria 
develop aqueous channels formed by porin molecules in the cell wall structure. Other 
distinguishing cell wall components of M.tb include ManLAM, LM, PIMs, and a peripheral 
layer of lipids such as trehalose mycolates (trehalose dimycolate or TDM, trehalose 
monomycolate or TMM), lipooligosaccharides (LOSs), phenolic glycolipids [PGLs, described 
in some M.tb clinical isolates (Reed et al., 2004;Torrelles et al., 2008b)], acyl trehaloses (diacyl- 
or DAT and triacyl- or TAT), triglycerides and sulfolipids (SLs) (Brennan & Nikaido, 1995; 
Muñoz et al., 1997a, 1997b). Recently, the role for individual components of the cell wall has 
been elucidated, and much emphasis has been placed on the identification and 
characterization of various genes that encode enzymes involved in the synthesis of the cell 
wall constituents. A better understanding of the cell wall components will lead to a better 
understanding of the relationship/symbiosis between M.tb and the infected host, which will 
lead to the identification of new drug targets and permit the development of new 
antituberculosis drugs targeting enzymes involved in the biosynthesis/maintenance of the 
cell wall within the host during infection. 
2.2.1 Cell wall core 
One distinguishing characteristic of the mycobacterial cell wall is the absence of lipoteichoic 
acids and lipopolysaccharides, typical structures of gram-positive and -negative bacteria, 
respectively. Instead, the M.tb cell wall has a cell wall core which is a covalently linked 
skeleton of the mAGP (Daffe et al., 1990). This structure is composed of the peptidoglycan, 
which is covalently linked to AG chains via phosphoryl-N-acetyl-glucosaminosyl-
rhamnosyl linkage units (--L-Rhap(1→3)-D-GlcNAc-P-) (Daffe et al., 1990; Mikusova et al., 
1996). AG non-reducing ends are esterified to a variety of -alkyl, -hydroxy mycolic acids. 
Lipoglycans, lipoproteins and especially free lipids are found to be associated with the 
mAGP complex (Andersen & Brennan P.J., 1994;Brennan & Nikaido, 1995). 
2.2.1.1 The peptidoglycan 
Peptidoglycan (PG) classes are identified by the type of peptide cross-linking that they 
display, the PG structure in M.tb is of the common A1 type, although it does have some 
distinguishing features (Schleifer & Kandler, 1972). The insoluble PG consists of alternating 
units of N-acetylglucosamine (GLcNAc) and modified muramic acid residues [N-acetyl--D-
glucosaminyl-(1→4)-N-acetylmuramic acid]. The typical N-acetyl groups in the muramic 
acid of bacterial PG are further oxidized to N-glycolyl groups in M.tb [N-glycolylmuramic 
acid]. The muramic acid residues are also modified by tetrapeptide [L-alanyl-D-
isoglutaminyl-meso-diaminopimelyl-D-alanine] side chains (Schleifer & Kandler, 1972). 
Cross-linking can occur between two meso-diaminopimelic acid (DAP) residues as well as 
between DAP and D-alanine residues (Crick et al., 2001). The free carboxyl groups of the 
glutamate and DAP in the murein peptides from M.tb can be amidated in essentially any 
combination and a small percentage of the D-glutamate residues are substituted with a 
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glycine. PG serves as a foundation structure forming the backbone of mAGP and provides 
shape, strength, and rigidity to the M.tb cell wall. Although the role of PG in pathogenesis 
has been shown for other bacterial species (Boneca, 2005), in the case of M.tb is still unclear 
(Table 1). However, recent studies have been focused on the role of nucleotide binding 
oligomerization domain (NOD)-like receptors (NLRs) (Franchi et al., 2008;Sirard et al., 2007) 
in the recognition of M.tb PG fragments. In particular the NLR Nod2, which resides within 
the phagocyte cytosolic compartment, is shown to recognize the M.tb PG fragment muramyl 
dipeptide (MDP), where the replacement of the N-acetyl group of the muramic acid of MDP 
with a N-glycolyl moiety seem to significantly increase the potency of this compound as a 
Nod2 agonist (Coulombe et al., 2009). Other studies confirmed that during infection, intra-
phagosomal M.tb is capable of stimulating the cytosolic Nod2 pathway, and this event 
requires membrane damage that is actively inflicted by the bacillus (Pandey et al., 2009). 
Moreover, M.tb bacilli recognized by Nod2 trigger NF-kB activation (Ferwerda et al., 2005) 
and production of IFN-/ with the subsequent transcription of CCL-5 (or RANTES) via 
Nod2, Rip2, Tbk-1, Irf3 and Irf5 cascade (Pandey et al., 2009). Recent studies by Brooks et al. 
using human macrophages showed that Nod2 plays a role in controlling pro-inflammation 
and M.tb intracellular growth (Brooks et al., 2011). This is in accordance with recent human 
polymorphisms studies linking Nod2 mutations to susceptibility to M.tb infection. 
2.2.1.2 The arabinogalactan 
The arabinogalactan (AG) is a heteropolysaccharide chain of furanoid arabinose (Araf) and 
galactose (Galf) (Daffe et al., 1990;McNeil et al., 1987). The furanosyl residues are arranged 
into three differential regions; the galactan core, the arabinan, and the non-reducing 
terminal segments of arabinan. Structural analysis of the AG shows that the galactan core of 
AG is composed by 5- and 6-linked -D-Galf residues (Daffe et al., 1990). The arabinan 
chains consist of linear 5-linked -Araf residues with branching introduced by 3,5-Araf 
residues (Daffe et al., 1990). The linkage of arabinan chains to the galactan core occurs at the 
C-5 of some of the 6-linked -D-Galf residues. Clusters of four mycolic acids are then 
attached to the terminal arabinofuranosyl motifs of non-reducing ends of the arabinan chain 
via ester linkage. Approximately two-thirds of the non-reducing ends of arabinan are 
mycolated at the 5 position of Araf residues (Daffe et al., 1993), one-third with succinyl and 
one-third with glucosaminosyl residues (Bhamidi et al., 2008). There are approximately 2-3 
arabinan chains attached to the galactan core (Baulard et al., 1998;Brennan and Nikaido, 
1995). Finally, the galactan core of AG, in turn, attaches to the C-6-position of muramic acids 
of the PG via a phosphodiester linkage of -L-rhamnopyranose (Rhap)-(1→3)-D-N-
acetylglucosamine (GlcNAc)-(1→phosphate) (McNeil et al., 1990;Mikusova et al., 1996). 
Although M.tb AG has serological activity (Kotani et al., 1971;Misaki et al., 1974), its capacity 
to generate the innate immune response is unknown (Table 1).  
2.2.1.3 Mycolic acids 
Mycolic acids are complex hydroxylated branched-chain fatty acids with characteristic 
carbon numbers (60-90 carbon atoms)(Barry et al., 1998). They may also contain diverse 
functional groups such as methoxy, keto, epoxy ester groups and cyclopropane rings 
(Asselineau & Lederer, 1950). Mycolic acids found in M.tb are composed of an -branch and 
a meromycolate branch, where the latter defines the heterogeneity in the mycolic acids, 
although the -branch length frequently also generates variation (Barry et al., 1998). The 
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possible functional groups (unsaturations, methyl branches and cyclopropanes) and polar 
moieties (ketones, methoxy groups) are localized only in the meromycolate branch (Barry et 
al., 1998). In particular for M.tb, unsaturated mycolates containing cyclopropanes (either 
cis/trans with sometimes an adjacent methyl branch), are known as -mycolic acids. Mycolic 
acids containing a methoxy group with double bond or cyclopropane ring are known as 
methoxymycolic acids; similarly, mycolic acids containing an -methyl-branched ketone are 
known as ketomycolic acids (Takayama et al., 2005). The -mycolate is the most abundant 
form found in the M.tb cell wall [65-70%] followed by methoxy- and keto-mycolates [8-15%] 
(Qureshi et al., 1978). The majority of the mycolic acids are localized in the inner leaflet of the 
M.tb cell wall covalently bound via carboxylate ester to form the non-extractable 
tetramycolyl-pentarabinosyl unit (McNeil & Brennan, 1991). However, mycolic acids can 
also be found loosely forming extractible lipids mainly in the form of TDM and TMM 
(Minnikin, 1982). In this case, it is thought that TDM and TMM stabilize their position 
within the cell wall by associating their mycolic acid lipid tails with the AG-covalent linked 
mycolates. In general, mycolic acids are involved in maintaining a rigid cell shape but they 
also contribute to the resistance to chemical injury and to the protection of the M.tb bacillus 
against hydrophobic antibiotics (Barry et al., 1998). The importance of the mycolic acids in 
the M.tb cell wall is defined by the action of isoniazid, which inhibits their biosynthesis and 
is an efficient antimycobacterial agent (Winder & Collins, 1970). Furthermore, looking at the 
biological functions described for mycolic acids (Table 1), it is noticable to point out that 
these were the first known CD1-presented antigens capable of stimulating and activating 
CD1b-restricted T cells (Beckman et al., 1994;Montamat-Sicotte et al., 2011;Moody et al., 
1999). Moreover, mycolic acids per se are shown to be immunomodulatory, where their 
structural nature (i.e. presence of determined functional groups) may determine the degree 
of virulence of a M.tb strain (Barry, et al., 1998). 
2.2.2 The peripheral lipid layer in the M. tuberculosis cell wall 
The study of mycobacterial lipids was initiated more than 70 years ago under the direction 
of Anderson in 1939 (Anderson, 1938). This field is still an active source of research due to 
the fascinating diversity of their structures and biological activities. The glycolipids are 
major M.tb cell wall constituents, known for their toxic or immunological properties 
(Brennan and Nikaido, 1995). They comprise the acyl trehaloses [mono- and dimycolyl 
trehalose (TMM, TDM), di- and triacyltrehalose (DAT, TAT) and sulfolipid (SL)], 
oligosaccharides containing lipids (lipooligosaccharides (LOSs), phenolglycolipid (PGL), 
apolar lipids such as the phthiocerol dimycocerosate (DIM), and the glycosyl derivatives of 
phosphatidyl-myo-inositol.  
Trehalose-containing glycolipids share a common -D-Glcp(1→1’) -D-Glcp unit and are the 
class of M.tb lipids that have been most extensively studied and still fascinate the majority of 
lipidologists and mycobacteriologists. TDM (or cord factor) was first obtained by Bloch 
(Bloch, 1950) after a petroleum ether extraction from cells of a virulent strain of M.tb.  The 
resulting extract was toxic when injected into mice and a drastic disorganization of the cords 
that M.tb formed at the culture medium surface was also observed. The toxic compound 
present in the extract was shown to be 6,6'-dimycoloyl--D-trehalose (Noll, 1956). TDM 
toxicity is due to an increase of the tissue specific nicotinamide adenine dinuclease activity 
decreasing the levels of NAD in several tissues by blocking the electron flow along the 
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mitochondrial respiratory chain and thus oxidative phosphorylation (Artman et al., 
1964;Barry et al., 1998;Brennan, 2003). During infection and when inside of the phagosome, 
M.tb is shown to produce large quantities of TDM (Fischer et al., 2001). From many studies 
done on TDM, it is remarkable that TDM induces lung granulomas and has 
immunostimulating properties (Bekierkunst, 1968) that are probably at the origin of its 
antitumoral activity (Bekierkunst et al., 1971a) (Table 1). TDM has also been shown to have 
adjuvant properties generating an optimal antibody response (Bekierkunst et al., 1971b) and 
a non-specific immune response against bacterial infections and parasitic infections ( 
Bekierkunst, 1968;Parant et al., 1977, 1978;Ribi et al., 1976;Yarkoni & Bekierkunst, 1976). 
Recent studies uncover that TDM is actively participating in blocking the mycobacterial 
phagosome maturation (Indrigo et al., 2003). Inhibition of the phagosome maturation is 
observed after phagocytosis of virulent strains of M.tb, allowing the bacillus to survive 
within the phagocyte (Schlesinger LS et al., 2008). Recently, Mincle (macrophage-inducible 
C-type lectin) (Yamasaki et al., 2008) on the macrophage surface, has been shown to 
recognize M.tb TDM, and working together with the Fcreceptor transmembrane segment 
induces pro-inflammation (Ishikawa et al., 2009; Schoenen et al., 2010). In the case of M.tb 
TMM, this is shown to be used by the bacillus to transfer mycolic acids towards molecules 
like the wall-linked AG. In agreement with this fact, the known secreted immunogenic Ag 
85 complex has been identified as a trehalose mycolyltransferase in M. smegmatis 
(Sathyamoorthy & Takayama, 1987) and later in M.tb (Belisle et al., 1997). TMM is also 
shown to have lethal toxicity, adjuvant activity, and capable of stimulating tumour necrosis 
factor via activation of the protein kinase C pathway (Numata et al., 1985)(Table 1). 
The sulfated trehaloses (sulfolipids, designated by SL) (Middlebrook et al., 1959) are also 
present in virulent strains of M.tb, specifically SL-1 (Goren, 1970a,1970b).  SL-1 can be 
acylated by 2 to 4 very long (up to C64) saturated and unsaturated, highly branched fatty 
acids. Sulfate derivatives are rare in natural substances, and some of the acyl chains of SL-1 
are also uncommon, since they are mainly highly branched in their carboxyl end (Goren & 
Mor, 1990;Leigh & Bertozzi, 2008). The SLs have attracted much interest since it was shown 
that, like TDM, they seem to inhibit phagosome-lysosome fusion in macrophages (Goren et 
al., 1976), and are cytotoxic (Kato & Goren, 1974a, 1974b). However, the role of SL-1 in M.tb 
pathogenesis seems to be dependent of the model system studied. In this context, results 
obtained from in vitro and in vivo studies (the latter using different animal models and M.tb 
strains) dispute the role of SL-1 in M.tb pathogenesis (Brozna et al., 1991;Gangadharam et al., 
1963;Goren et al., 1974, 1982;Pabst et al., 1988;Rousseau et al., 2003;L. Zhang et al., 1988, 1991). 
While SL-1 has been shown to induce specific host cell responses, such as inhibition of 
phagocyte priming/activation (Brozna et al., 1991;Pabst et al., 1988), its mechanism of action 
is still unclear; although a role of a guanine nucleotide binding protein in both priming and 
direct activation of neutrophils by SL-1  has been suggested (L. Zhang et al., 1991) (Table 1). 
Diacyltrehalose (DAT, a 2, 3-diacyltrehalose) and triacyltrehalose (TAT, a 2, 3, 6-
triacyltrehalose) (Gautier et al., 1992), who’s acyl groups are mainly branched polymethyls, 
are also present in the M.tb cell wall. The main use of these glycolipids is in M.tb sero-
diagnosis (Muñoz et al., 1997a). However, a study recently showed that M.tb mutants 
lacking DATs and sulphoglycolipids cannot block phagosome maturation and thus, 
revealing the importance of these molecules in the M.tb pathogenesis (Table 1)(Brodin et al., 
2010). In M.tb, other trehalose-based lipids are lipooligosaccharides (LOSs), which contain a 
polyacylated trehalose with long chain fatty acids and an oligosaccharide. It contains 2 or 3 
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straight or methyl-branched chains. In some LOSs, acyl residues can be distributed between 
the two glucose residues of the trehalose end of the polymer. Depending on the species, an 
oligosaccharide (2 to 6 sugar residues) is linked either on carbon 3, 4 or 6 of the trehalose 
end (Gilleron et al., 1994;Hunter et al., 1985). Pyruvic acid residues (carboxyethylidene) can 
also be present, giving an anionic character to the molecule. LOSs have been considered to 
be immunogenic and also phage receptors (Besra & Chatterjee, 1994), suggesting that they 
are located in the M.tb cell wall surface. Other M.tb lipids containing oligosaccharides are 
the phenolic glycolipids (PGLs). These have been extensively studied in Mycobacterium leprae 
(PGL-I) (Hunter et al., 1983;Hunter & Brennan, 1981). Leprosy patients have antibodies 
against this molecule, and therefore it is a useful diagnostic tool (Cho et al., 1983). PGLs have 
been found in the Canetti strain of M.tb (Daffe et al., 1987) (PGL-Tb), however, 
serodiagnostic studies have shown that there were large variations among tuberculous 
patients in the response to this antigen (Daffe et al., 1991). This is likely due to large 
differences in phenolglycolipid amounts produced by different M.tb strains (Cho et al., 1992; 
Torrelles et al., 2008b). Recently, the hypervirulent phenotype observed in several strains of 
M.tb (i.e. strain HN878) has been associated with the presence of PGL in their cell wall (Reed 
et al., 2004).  
There are many apolar lipids described forming part of the cell wall of M.tb, however, of 
particular importance is the phthiocerol dimycocerosate (or PDIM/DIM). PDIM is a major 
apolar lipid present in the cell wall of M.tb. PDIM is considered a wax containing multiple 
methyl and/or methylene groups (Brennan, 2003). Several studies have tied, as in the case of 
TDM and SL-1, the presence of PDIM to M.tb virulence (Goren & Brennan, 1980). In vivo 
studies using M.tb strains depleted of PDIM show attenuation in the growth of these strains 
in mice (Cox et al., 1999;Ferwerda et al., 2007), in accordance with previous studies in Guinea 
pigs using a M.tb clinical isolate lacking PDIM in its cell wall (Goren & Brennan, 1980) 
(Table 1). Recent studies using a genetically engineered M.tb PDIM mutant concluded that 
PDIM inserts into the host membrane and participates both in the receptor-dependent 
phagocytosis of M.tb and the prevention of phagosomal acidification (Astarie-Dequeker et 
al., 2009). Using PDMI mutants also is shown that these are required for M.tb resistance to 
an IFN--mediated immune response that is independent of NOS2 (Kirksey et al., 2011). 
Glycosyl derivatives of phosphatidyl-myo-inositol in the M.tb cell wall are the phosphatidyl-
myo-inositol (PI) and its mannosylated derivatives known as phosphatidyl-myo-inositol 
mannosides (PIMs), phosphatidylethanolamine, phosphatidylglycerol, diphosphatidyl-
glycerol, cardiolipin, and glycosylphosphopolyisoprenols. PI and its mannosylated 
derivatives are important lipids in the cell wall of M.tb, both as key membrane constituents 
and as participant in essential M.tb-host interactions and metabolic processes. PI is an acidic 
(anionic) phospholipid that in essence consists of a phosphatidic acid backbone, linked via 
the phosphate group to inositol (hexahydroxycyclohexane). In mycobacteria, the 
stereochemical form is myo-D-inositol. As early as 1930’s, it was recognized by Anderson 
that the phospholipidic fraction extracted from M.tb and related mycobacteria contained 
inositol and mannose (Anderson, 1938). Besides phosphatidylethanolamide, PIMs are the 
major phospholipid components of the M.tb cell wall (Brennan, 2003). PIMs are found as a 
mixture of compounds differing one from the other by the number of mannosyl residues 
and fatty acids. Their structures consist of a mannosyl unit attached to position C-2 of the 
myo-inositol of a PI anchor. Position C-6 of myo-inositol is further substituted by an -D-
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mannosyl or a linked trimannosyl unit, giving PIM2 and PIM4, respectively. PIM4 may be 
further substituted at position C-2 by a -D-mannosyl leading PIM5, which can also be 
further substituted at the same position leading PIM6 [-D-Manp(1→2)--D-Manp(1→2)-
-D-Manp(1→6)--D-Manp(1→6)--D-Manp(1→6)-myo-inositol], the higher PIM 
encountered in mycobacteria (Torrelles & Schlesinger, 2010). Studies have shown that 
PIMs, which are known to interact with the plasma membrane, are also present on the 
M.tb cell wall surface (Ortalo-Magné et al., 1996). The intrinsic heterogeneity of PIMs is 
evident looking at their carbohydrate constitution (PIM to PIM6). A difficulty is added, 
however, when we look at the acylation sites of the PIMs. Many studies have shown 
evidence for multiacylated forms of PIMs in M.tb [reviewed in (Torrelles & Schlesinger, 
2010)]. Differences in the degree of acylation and the kind of fatty acid linked was studied 
in detail by Khoo et al. (Khoo et al., 1995), who confirm the existence of triacylated PIMs 
(Ac1PIMx) esterified by palmitic (16:0) and tuberculostearic (TBST or 10-methyl-
octadecanoic) acids, and discussed the presence of tetracylated PIMs (Ac2PIMx), where an 
additional fatty acyl could be carried in the myo-inositol ring. This fact was later 
corroborated by Gilleron et al. (Gilleron et al., 1999) showing an unambiguous localization 
of a fourth fatty acid on the C-3 of the myo-inositol beside the fatty acids on C-1 and C-2 
position of the glycerol and on the C-6 position of the (1→2) linked mannose. PIMs can be 
grouped in lower- and higher-order depending of the number of mannoses, where lower-
order PIMs contain 1 to 4 mannoses and higher-order PIMs contain 5 to 6 mannoses 
(Torrelles et al., 2006). The most common PIMs found are AcPIM2 and Ac1PIM2 (di- and 
triacylated PIM2) and AcPIM6 and Ac1PIM6 (di-and triacylated PIM6) (Khoo et al., 1995). 
Lower-order PIMs have a terminal (1→6)-mannose and are shown to participate in the 
phagocytosis process through association with the non-opsonic domain of complement 
receptor-3 (Villeneuve et al., 2005), and also participate in trafficking processes within the 
phagocyte by facilitating early endomal fusion with phagosomes (Vergne et al., 2004). 
Higher-order PIMs have a terminal (1→2)-mono- or di- mannoside (AcxPIM5  or 
AcxPIM6, respectively) similar to the mannose caps of mannose-capped 
lipoarabinomannan [see section 2.2.2.1 for details].  Only triacylated forms of higher-order 
PIMs are shown to interact with the mannose receptor (MR) and interfering with 
trafficking pathways by limiting phagosome-lysosome fusion (Torrelles et al., 2006). 
Moreover, several studies have also shown that all M.tb PIMs interact with dendritic cell-
specific ICAM-3-grabbing non-integrin (DC-SIGN) (Torrelles et al., 2006), although 
differences in DC-SIGN PIM recognition specificity may be species dependent (Driessen et 
al., 2009). Additional studies have also shown that cytosolic soluble CD1e is involved in 
PIM6 processing and presentation via CD1 with subsequent T cell activation (de la Salle et 
al., 2005) (Table 1). 
Apart from the mannosides of phosphatidylinositol, there are other mycobacterial 
phosphodiacylglycerol, whose origins are based on phosphatidic acid. These are 
phosphatidylglycerol, diphosphatidylglycerol (DPG) and phosphatidylethanolamine. 
Although the role of these M.tb cell wall phospholipids during infection is uncertain, M.tb 
cardiolipin (a DPG molecule) is shown to be processed into lysocardiolipin by the lysosomal 
phospholipase A2 during M.tb infection (Fischer et al., 2001). Antibodies against M.tb 
cardiolipin are also found in sera from TB patients (Santiago et al., 1989), and their 
production is shown to be strictly related to IL-4 and T cells (Fischer et al., 2002). Anti-
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cardiolipin antibodies are also capable of activating complement (Santiago et al., 1991). Small 
quantities of glycosylphosphopolyisoprenols, which are involved in M.tb cell wall 
biosynthesis, have also been isolated from the cytoplasmic membranes of M.tb, where 
ribosyl-, mannosyl- and arabinosyl-phosphopolyprenols have been characterized 
(Takayama et al., 1973; Takayama & Goldman, 1970; Wolucka & De Hoffmann, 1995). 
In summary, M.tb elaborates a great variety of glycolipids of rather unusual structure. 
Some of these lipids are abundant in the inner cell wall and others are exposed on the 
bacillus surface. These include acylglucosides, sulfatides, lipooligosaccharides, phenolic 
glycolipids, dimycocerosates, and the ubiquitous phosphatidyl-myo-inositol-mannosides. 
Some of these glycolipids are described as virulence factors helping M.tb to survive as 
intracellular ‘parasites’ that infect and reside in the host cell. The biological activities 
attributed to these surface-exposed glycolipids may derive, at least in part, from the 
modulation of cell functions through the interactions between host membranes and them, 
whose structures are different from those of mammalian cell membrane components. 
Biologically active glycolipids have been shown to profoundly affect the physical and 
functional properties of biologic membranes (Brandley & Schnaar, 1986) as well as inhibit 
both macrophage antimicrobial activities and lymphocyte proliferation (Vergne & Daffe, 
1998). Therefore, the enzymes involved in their biosynthesis may represent potential drug 
targets (Kaur et al., 2009). Nevertheless, for some of these lipids confirmation of their role 
in M.tb pathogenicity is still lacking, opening the necessity to genetically manipulate M.tb 
to obtain glycolipid deficient mutants. These mutants may be unable to elaborate 
determined glycolipid thought to be involved in M.tb pathogenesis. Thus, the lack of 
specific glycolipids in virulent strains of M.tb may help us to understand their real 
implication in pathogenesis. 
2.2.3 Lipoglycoconjugates of the M. tuberculosis cell wall 
An extensive study of the mannose-capped lipoarabinomannan (ManLAM) has been 
performed in M.tb [reviewed in (Torrelles & Schlesinger, 2010)]. M.tb ManLAM is an 
extremely heterogeneous lipoglycan with a defined tripartite structure that possesses a 
carbohydrate core, a mannosyl-phophatidyl-myo-inositol anchor (MPI) and various capping 
motifs. Following the earlier work performed by Chatterjee and co-workers (Chatterjee & 
Khoo, 1998), a series of detailed structural analyses have produced evidence of this tripartite 
structure, in which ManLAM was distinguished from the related lipomannan (LM) by 
virtue of having an additional immunodominant arabinan domain that extends from a 
common phosphatidyl-myo-inositol mannan core in an as yet undefined manner. The 
polysaccharide core of M.tb ManLAM consists of two very well differentiated polymers, a 
D-mannan and a D-arabinan. The D-mannan structure consists of a linear (1→6) linked 
mannopyranosyl backbone that is linked to a phosphatidyl-myo-inositol anchor, and 
presents substitutions/ branches on their C-2 with another single mannose (-D-
Manp(2→1)t--D-Manp). The D-mannan size and the degree of branching can vary among 
M.tb strains. This mannosyl backbone carries an unknown number of branched arabinosyl 
side chains, which form the D-arabinan. To date, the linkage between the arabinan polymer 
and the D-mannan core is still not determined. The arabinan is based on the rare -D- 
arabinofuranose (Araf), and consists of a branched linear (1→5) linked Araf backbone. 
Branching residues carry an additional (1→3) linked Araf. At its non-reducing end we can 
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find two types of arrangements or motifs, a linear tetraarabinofuranoside (Ara4) defined as 
-D-Araf-(1→2)--D-Araf-(1→5)--D-Araf-(1→5)--D-Araf and a branched hexaarabino-
furanoside (Ara6) defined as [-D-Araf-(1→2)--D-Araf-(1→]2-3 and 5--D-Araf-(1→5)--D-
Araf. In the case of slow-growing mycobacteria like M.tb, M. leprae and M. bovis BCG, some 
of the terminal arabinan motifs are extensively capped at C-5 with one or more -mannoses 
attached to these -Araf termini. The mannooligosaccharides linked to the terminal -Araf 
thus define ManLAM. The mannose caps are defined as a single Manp, a dimannoside (-D-
Manp-(1→2)--D-Manp) or a trimannoside (-D-Manp-(1→2)--D-Manp-(1→2)--D-Manp). 
These units are located in both tetra- and hexaarafuranosyl motifs of the arabinan non-
reducing terminal (Chatterjee et al., 1993). Data reported from different studies shown that 
the disaccharide unit is the cap most frequently found in both linear (Ara4) and branched 
(Ara6) termini. Man2Ara4 and Man4Ara6 are then the most frequent motifs in all ManLAM 
studied (Chatterjee et al., 1993), however, trimannoside caps in the linear Ara4 have also 
been found (i.e. Man3Ara4), and in the branched Ara6, all three combinations of mannose 
caps have been found, i.e. (Man[(1 to 3)x2] Ara6). The degree of ManLAM capping varies 
according to the M.tb strain studied, where M.tb Erdman is the most capped when 
compared to M.tb H37Rv and H37Ra strains [reviewed in (Torrelles & Schlesinger, 2010)]. The 
anchor structure in M.tb ManLAM is similar to the one in PIMs, and consists in an ns-
glycerol 3-phospho-(1-D-myo-inositol) unit with a -D-mannopyranosyl residue at C-2 of 
the myo-inositol (MPI). In the C-6 position of this myo-inositol there is O-linked the mannan 
polymer described previously (Chatterjee & Khoo, 1998). Some of the heterogeneity that 
characterizes ManLAM occurs through the number, the location, and the nature of the 
fatty acids esterifying the PI anchor. The characteristic fatty acids described in the 
ManLAM anchor are 16:0 and TBST (Hunter et al., 1986). However, traces of stearic (18:1), 
myristic (14:0), heptadecanoic (17:0), 10-methyl-heptadecanoic, 12-O-(methoxypropioryl)-
12-hydroxy-stearic and 12-hydroxy-tuberculostearic acids have also been described 
(Leopold & Fischer, 1993;Nigou et al., 1997). The average number of fatty acids per 
ManLAM molecule cannot be generalized. Some studies confirmed an average of 3 fatty 
acids per molecule of ManLAM in positions 1 and 2 of the ns-glycerol and position 6 of 
the Manp unit linked to C-2 of the myo-inositol (Khoo et al., 1995). Studies by Chatterjee 
and colleagues performed in an ethambutol resistant strain of M.tb supported the 
existence of tetraacylated ManLAM as the most common molecular form (Torrelles et al., 
2004). Thus, the only fact that can be generalized is that, with the exception of the lyso-
forms of ManLAM (only one fatty acid in the ManLAM anchor), ManLAM at least has 
two fatty acids, with both fatty acids in the ns-glycerol unit, where  16:0 and TBST are at 
position 1 and at position 2, respectively.  
The presence of additional acyl groups on ManLAM has been reported by several authors. 
Hunter et al. reported the existence of succinates and lactates (Hunter et al., 1986). Delmas et 
al. used nuclear magnetic resonance spectroscopy to locate the succinic groups (1 to 4 per 
molecule) in the C-2 of the 3,5--D-Araf and/or 5--D-Araf residues in ManLAM from 
different Mycobacterium bovis BCG strains (Delmas et al., 1997). Later, studies performed by 
Chatterjee and colleagues analyzing the content of succinates in ManLAMs from different 
mycobacterial species and strains showed that Mycobacterium leprae, the M.tb laboratory 
strain H37Rv, and a M.tb clinical isolate (CSU 20) had also succinates (Torrelles et al., 2004); 
where ManLAM from M. leprae, the laboratory strain H37Rv, and CSU20 had an average 
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number of 7, 2 and 4 succinates, respectively. The succinates biological function in ManLAM 
is still a question to be resolve. Our recent studies show that a biosynthetically related 
lipoglycan to ManLAM, the lipomannan, also contains succinates, where succinates seem to 
influence CD1-Ag presentation to T cells and subsequent T cell activation (Torrelles et al., 
2011). Recently, Treumann et al. using nuclear magnetic resonance spectrometry defined a 
new terminal sugar located in the caps of M.tb ManLAM (Treumann et al., 2002). This sugar 
consisted in a 5-deoxy-5-methylthio-ǂ-xylofuranosyl (MTX), and may be involved in M.tb-
host interactions battling the effects of reactive oxygen species by adding to the antioxidant 
properties of ManLAM (Turnbull et al., 2004). The orientation of LAM in the M.tb cell wall is 
still unresolved. There are many hypotheses, but the most accepted is that ManLAM is 
anchored by its lipidic anchor into the plasma membrane, and projects through the 
thickness of the wall so that its terminal arabinose or mannose-capped arabinose units are 
accessible to the outside (McNeil & Brennan, 1991). Other possibilities are that ManLAM is 
interacting by its lipid anchor with the mycolic acid layer and with other polar wall 
associated lipids (Rastogi, 1991), or that ManLAM has a non-permanent location in the cell 
wall, and is essentially a secreted molecule in transit through the envelope. The many 
studies carried out on ManLAM have led to data that supports each of these hypotheses. For 
example, Lemassu and Daffe demonstrate the existence of non-PI containing mannose-
capped arabinomannan in the so called capsular/outer material polysaccharide associated 
with M.tb (Lemassu & Daffe, 1994). Other studies, subdivided ManLAM into two different 
kinds, the parietal ManLAM and the cellular ManLAM. Both had similar core structure 
presenting remarkable differences in the degree of mannose-capping and the acylation of 
the PI-anchor (Gilleron et al., 2000). The fact that the parietal LAM is obtained without cell 
disruption reinforces the hypothesis of two different locations for ManLAM. Thus, 
ManLAM may be firmly, but not covalently, attached to the M.tb cell wall and it may also be 
anchored to the plasma membrane. The biological function of M.tb ManLAM is discussed 
later in this chapter (see also Table 1), and information about its biosynthesis pathway(s) can 
be found elsewhere (Kaur et al., 2009). 
Another remarkable lipoglycan in the M.tb cell wall is lipomannan (LM). The  (1→6) 
mannose polymer of LM presents identical characteristics to the mannan backbone of 
ManLAM. The mannan of LM is directly attached to position C-6 of the myo-inositol of its 
MPI anchor. The M.tb ManLAM and LM MPI anchor is indistinguishable from the M.tb 
dimannosylated phophatidyl-myo-inositol (AcxPIM2), the structure of which was established 
by Lee and Ballou (Lee and Ballou, 1965). LMs are considered multimannosylated forms of 
PIMs by the fact that both types of molecules have an elaborated anchor in common 
(Gilleron et al., 1999). Their common structure with ManLAM also enforces the hypothesis 
that LM is a precursor of ManLAM (Besra et al., 1997). However, it seems that LM could also 
be a co-lateral final product in the biosynthetic pathway of ManLAM (Besra et al., 1997). Few 
biological properties of M.tb LM have been described, mainly because this molecule is still 
understudied (Table 1).  
Mycobacterial LM is shown to regulate cytokine, oxidant and T cell responses (Barnes et al., 
1992; Chan et al., 2001;Gilleron et al., 2001). M.tb LM is shown to associate with DC-SIGN 
and not with the MR (Torrelles et al., 2006), and to induce apoptosis and a pro-inflammatory 
response through TLR2 (Dao et al., 2004;Nigou et al., 2008). However, recent studies  
showed that although M.tb LM is capable of activating macrophages via TLR2  inducing 
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signaling cascades required for TNF mRNA expression, the TNF mRNA produced is poor 
translated and faster degraded (Rajaram et al., 2011). 
M.tb cell 
wall 
location 
M.tb cell wall 
component 
Host Cell 
Receptor(s) 
Phagosome 
maturation 
blockade 
Host Immune 
Response 
Sero- 
activity 
Cyto- 
toxicity 
Outer 
Material 
-Glucan DC-SIGN, 
CR3? 
No Anti-
inflammatory
Unknown ND 
Cell wall 
Core 
Peptidoglycan  
(PG)-MDP 
Nod2 ND Pro-
inflammatory
Unknown ND 
Arabinogalactan 
(AG) 
ND ND ND Yes ND 
Mycolic Acids CD1 (in Ag- 
presentation 
ND Pro-
inflammatory
Yes Yes 
Peripheral 
lipid layer 
Trehalose 
dimycolate (TDM) 
Mincle-FcR 
TLRs 
Yes Pro-
inflammatory
Yes Yes 
Trehalose 
monomycolate 
(TMM) 
ND ND Pro-
inflammatory
Yes Yes 
Sulfolipid-1  
(SL-1) 
ND Yes Pro-
inflammatory
Yes Yes 
Diacyl- and Triacyl-
trehalose (DAT & 
TAT) 
ND Yes Pro-
inflammatory
Yes ND 
Lipooligosaccharide
s (LOSs) 
ND ND Pro-
inflammatory
Yes ND 
Phenolic glycolipid 
(PGL-TB) 
CR3? ND Pro-
inflammatory
Yes Yes 
Triglycerides TLRs ND Pro-
inflammatory
Unknown Yes 
Phthiocerol 
dimycocerosate 
(PDIM) 
Direct 
insertion into 
host Mbrs 
Yes Pro-
inflammatory
Unknown Yes 
Lower-order 
phosphatidyl-myo-
inositol mannosides 
(PIMs) 
CR3, TLRs, 
DC-SIGN 
No Pro-
inflammatory
Yes ND 
Higher-order 
phosphatidyl-myo-
inositol mannosides 
(PIMs) 
MR,  
DC-SIGN 
Yes (through 
the MR only)
Anti-
inflammatory
Yes ND 
Lipomannan (LM) TLRs,  
DC-SIGN 
No Pro-
inflammatory
Yes ND 
Mannose-capped 
lipoarabinomannan 
(ManLAM) 
MR,  
DC-SIGN 
Yes (through 
the MR only)
Anti-
inflammatory
Yes ND 
Mbrs: Membranes.  
Table 1. M.tb cell wall components and their interaction with the host outcome.  
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Due to the complexity of the cell wall of M.tb, we may need to be careful when assessing the 
essentiality of a specific cell wall component thought to be a virulence factor. Current 
strategies are directed in creating isogenic strains of M.tb deficient in the production of a 
specific virulent factor. We may not obtain the real answer by just depleting the presence of 
a potential virulent factor in the cell wall of M.tb.  In this context, efforts to discern the 
enzymes involved in the biosynthetic pathways of the M.tb lipids are critical to address their 
essentiality in M.tb survival. These will allow us to uncover novel drug targets. However, 
when evaluating the role of the omitted/mutated lipid in M.tb pathogenesis, we need to be 
careful in considering the rearrangement that the M.tb cell wall may suffer upon the lack of 
a specific lipid. Depending of the structural nature of the lipid depleted from the M.tb cell 
wall (i.e. size, charge, hydrophobicity, etc.), we may find that the bacterial cell wall is altered 
in a way that the absence of the lipid is unexpectedly compensated. This is the case for SL-1, 
where the lack of this lipid in M.tb isolates is being linked to TB pathogenesis, however, 
studies performed by Jackson and colleagues clearly showed that when using an isogenic 
SL-1 mutant, SL-1 deficiency did not affect M.tb virulence (Rousseau et al., 2003). As Jackson 
and collaborators stated in this study, there are several explanations behind this observed 
discrepancy, but one of them is related to the presence of a potent attenuator lipid in the 
clinical isolates lacking SL-1 that compensated the SL-1 phenotype (Goren et al., 1982). Other 
factor to account for is the synergy between M.tb lipids; this is also observed for SL-1 and 
TDM, where purified SL-1 alone at high doses was innocuous, but when administered 
simultaneously with TDM, a synergistic increase in the TDM cytotoxicity was observed 
(Kato & Goren, 1974a, 1974b). Thus, indicating that the lack of a specific lipid may also 
significantly alter the cytotoxic properties of other M.tb cell wall components.  Finally, we 
will need to consider evaluating the constitution of the M.tb cell wall during infection. Are 
the properties of the M.tb cell wall altered during infection? Some studies indicate that this 
may happen in the case for TDM, which is overproduced during M.tb infection (Backus et 
al., 2011;Fischer et al., 2001). Why do clinical isolates of M.tb present different cell wall 
rearrangements than the widely studied M.tb laboratory strains Erdman, H37Rv, and H37Ra? 
In this context, hypervirulent M.tb strains of the Beijing family (Tsenova et al., 2005) are 
shown to contain large amounts of triglycerides (Reed et al., 2007), and some of them also 
contain the PGL-TB (Reed et al., 2004). M.tb clinical isolates deficient in ManLAM and PIMs 
surface exposure, but presenting in their cell wall large quantities of triglycerides, PGL-TB, 
and dimycocerosates, are also shown to have reduced phagocytosis but faster intracellular 
growth rate in human macrophages (Torrelles et al., 2008b). These studies performed by 
Schlesinger and colleagues concluded that the clinical spectrum of TB is not only dictated by 
the host but also it may be related to the amounts and ratios of specific surface-exposed M.tb 
adherence factors defined by M.tb strain genotype (Torrelles et al., 2008b;Torrelles & 
Schlesinger, 2010). Is this M.tb genotypic/phenotypic adaptation due to their multiple 
passages through the host? Triglycerides and DIMs are a major part of the peripheral lipid 
layer in the M.tb cell wall; however, their role in pathogenesis has been until recently 
overlooked due the presence of other hydrophilic and hydrophobic cell wall components 
more attractive to TB researchers due to their potential (or already established) role in 
dictating M.tb-host cell interactions. Other questions demanding answers refer to the 
structural properties of the cell wall of MDR-, XDR-, XXDR, and TDR-M.tb strains. What is 
the cell wall constitution of these strains? Studies performed using transmission electron 
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and atomic force microscopy techniques started to dig into this question showing that MDR-
, XDR-, XXDR- and TDR- strains have thicker cell wall and rougher cell surface (supposedly 
produced by the progressive erosion of their cell wall by the action of the drugs) with 
tubular extensions than susceptible strains (Velayati et al., 2009a, 2010). Because some XDR- 
and TDR-M.tb strains are related to the Beijing family (Velayati et al., 2009b), which are 
shown to have their cell wall overpopulated with triglycerides, it is plausible to question 
any relationship between the abundance of a specific hydrophobic lipid on the M.tb cell wall 
and drug resistance. Many of these questions remain unanswered. 
3. M.tb-Host interface 
The initial recognition of M.tb by the host is quite complex and involves alveolar resident 
cells and many of their surface receptors.  The concept of studying the contribution of a 
specific receptor(s) in the M.tb recognition and/or uptake is critical to our understanding of 
the pathway(s) that the bacillus exploits to gain entrance into the host cell minimizing or 
triggering the immune response. However, it is important to link the results obtained 
studying a specific receptor to the existence of other receptors that may also participate at 
the same time in recognizing M.tb generating a completely different outcome. Normally the 
outcome of M. tuberculosis-host recognition is beneficial for the host, triggering the innate 
immune response; however, engagement of M.tb with specific phagocytic receptors is 
shown to be beneficial for M.tb leading to a pathway of survival and subversion of the 
immune response. Here we will describe the host phagocytic and signaling receptors [some 
of them known as a pattern recognition receptors, PRRs, for their unique capability to 
recognize specific motifs on the M.tb cell surface (these motifs are also known as 
pathogen/microbial-associated molecular patterns, PAMPs/MAMPs)] involved in M.tb 
recognition and the subsequent inflammatory response attending in our discussion to the 
fact that M.tb recognition simultaneously includes multiple receptors.  
3.1 Phagocytic receptors 
The encounter of M.tb with the host triggers the phagocytosis process. This process depends 
of two important factors; one is the constitution of the cell wall of M.tb (which is strain 
dependent) and the surface receptor repertoire present on the phagocyte (which is host cell 
dependent). Mainly M.tb infections occur by airborne transmission of droplet nuclei 
containing few viable bacilli. The first contact between M.tb and the human host cell is 
within the alveolar space of the lung. When M.tb reaches the alveolar space, resident 
alveolar macrophages (AMs), and alveolar epithelial cells together with recruited 
monocytes, neutrophils, lymphocytes and fibroblast represent the array of immune cells that 
participate in host defense. Phagocytic receptors involved in M.tb recognition by the host 
mainly are: the mannose receptor (MR), DC-SIGN, and complement receptors (CRs). M.tb 
uptake by these receptors leads to the formation of an M.tb containing phagosome with 
different outcomes as noted below (Table 1). 
3.1.1 The mannose receptor 
The cell wall of certain M.tb strains has been characterized to be heavily mannosylated with 
molecules exposing their (1→2)-Manp termini on the bacterial surface acting as ligands for 
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host cell receptors contributing to M.tb pathogenesis (Torrelles & Schlesinger, 2010). These 
molecules are ManLAM, LM, PIMs, arabinomannan, mannan, and mannosylated 
glycoproteins. The MR is conceived as a homeostatic receptor, whose main function is the 
recycling of endogenous highly N-mannosylated glycoproteins normally generated during 
inflammation (Martinez-Pomares et al., 2001). Studies by Schlesinger and colleagues have 
suggested that M.tb may be capable of using its surface mannose coating to gain entrance 
and survive within the host cell by associating with the MR. In this context, we 
demonstrated that M.tb can use two of its mannosylated cell wall components, ManLAM 
and higher-order PIMs, to associate with the MR, leading to a pathway of intracellular 
survival within the host by blocking phagosome acidification (Kang et al., 2005;Torrelles et 
al., 2006). Association with the MR has also been shown to reduce microbicidal activities by 
down-regulating the generation of pro-inflammatory cytokines, nitric oxide, oxygen radicals 
and by blocking M.tb-induced Ca2+-depending apoptosis[reviewed in (Torrelles et al., 
2008a)]. In particular, M.tb ManLAM has been shown to  interact with the MR triggering an 
anti-inflammatory response by blocking the production of inflammatory cytokines such as 
TNF and IL-12, and inducing the generation of IL-10 and TGF- (Astarie-Dequeker et al., 
1999;Chieppa et al., 2003;Nigou et al., 2001)(Table 1). Recently, studies by Schlesinger and 
colleagues showed that engaging of the MR by ManLAM and/or virulent M.tb upregulates 
the peroxisome proliferator-activated receptor-gamma (PPAR-, a transcription factor 
showed to be important in regulating the inflammatory response) leading to a simultaneous 
increase in the generation of CXCL-8 (or IL-8), expression of cycloxygenase 2 (COX2), and 
production of prostaglandin 2 (PGE2) (Rajaram et al., 2010).  Moreover, this study depicts 
how M.tb negatively regulates protective inflammatory modulators through the MR, where 
engaging of the MR down-regulates TNF levels via PPAR- (Rajaram et al., 2010). In addition 
to M.tb ManLAM blocking the generation of TNF via the MR, Schlesinger and colleagues 
also identified a novel molecular and cellular mechanism underlying the ability of another 
major M.tb cell wall component, the LM, to block TLR2 induced biosynthesis of TNF in 
human macrophages, thereby allowing M.tb to subvert the host immune response and 
potentially increase its virulence (Rajaram et al., 2011). 
3.1.2 DC-SIGN 
M.tb is shown to associate with dendritic cell–specific ICAM-3-grabbing non-integrin  (or 
DC-SIGN) (Geijtenbeek et al., 2000) through is cell surface cell wall components ManLAM, 
LM and PIMs [reviewed in (Ehlers, 2009)](Table 1). Recently, -glucan was also described as 
another M.tb cell wall ligand for DC-SIGN (Geurtsen et al., 2009). Binding of M.tb to DC-
SIGN in DCs leads to bacterial killing by acidification of the M.tb phagosome (Geijtenbeek et 
al., 2003). However, the implication of DC-SIGN in triggering the immune response is still 
controversial. On one hand, engaging of M.tb, mannosylated cell wall components, or -
glucan has been shown to induce generation of anti-inflammatory modulators such as IL-10 
(Ehlers, 2009;Geurtsen et al., 2009). These findings were supported by in vivo studies using 
mice expressing human DC-SIGN homologues (McGreal et al., 2005;Park et al., 
2001;Powlesland et al., 2006) or transgenic mice expressing human DC-SIGN, showing that 
DC-SIGN may act damping the immune response, and thus, promote host protection by 
limiting tissue damage (Schaefer et al., 2008;Tanne et al., 2009;Wieland et al., 2007). On the 
other hand, another study concluded that the ManLAM-PIM/DC-SIGN pathway may not 
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be significantly involved in regulating cytokine secretion using an engineered M. marinum 
strain lacking essential mannosylated components (Appelmelk et al., 2008).  
3.1.3 Complement receptors 
Complement receptors are described on the surface of all mononuclear phagocytes. In M.tb 
phagocytosis CR1, CR3 and CR4 have been implicated (Fenton et al., 2005). Several studies 
have established the role of the complement component 3 (C3) in M.tb opsonization. C3 
deposition in the form of C3b and C3bi happens quickly via covalent linkages with cell wall 
components located on the M.tb surface (Ferguson et al., 2004). As C3 opsonization depends 
of serum levels in the tissue, it is still unknown how C3 opsonization varies in form 
(classical and/or the alternative pathways) and amount among different stages of M.tb 
infection or tissue sites. M.tb surface-exposed lower-order PIMs (i.e. PIM2) and specific 
polysaccharides have been shown to directly interact with the lectin domain of CR3 (Cywes 
et al., 1997;Hoppe et al., 1997;Villeneuve et al., 2005) and thus, presumably mediate M.tb 
uptake by macrophages (Table 1). PGL-TB from M.tb may also interact with CR3, as this is 
the case for the structurally related PGL-1 from M. leprae (Tabouret et al., 2010). Although 
CR3 seems to drive M.tb uptake under opsonic and non-opsonic conditions, in vitro and in 
vivo studies using wild type and CR3-deficient mice did not show differences in lung 
pathology and bacterial burden (Hu et al., 2000), and thus CR3 role in in vivo infections 
remains unanswered. Less attention has been put into CR4, which together with the MR, is 
highly expressed on AMs and other cells involved in M.tb uptake (Hirsch et al., 1994;Zaffran 
et al., 1998;Schlesinger et al., 2008), and thus may be playing a major role in the uptake of 
M.tb by the naïve host in early stages of infection. 
3.2 Signaling receptors  
Apart from the phagocytosis process, M.tb also is shown to signal through specific signaling 
receptors located on the host cell surface and/or cytosol.  The main signaling receptors for 
M.tb are Toll-like receptors (TLRs), and nucleotide-binding oligomerization domain-like 
(NODs) receptors.  
3.2.1 Toll-like receptors 
TLRs are a set of PPRs expressed on many cell types but their function on phagocytes is 
particularly important [reviewed in (Kawai & Akira, 2010)]. On macrophages TLRs are 
either expressed on the surface (like TLR2 and 4) or inside cell compartments (like TLR8 and 
9) (Kawai & Akira, 2010). TLRs detect a wide range of PAMPs on M.tb, which activates the 
innate immune response and enhance adaptive immunity by mediating the secretion of 
various pro-inflammatory cytokines along with other anti-bacterial modulators (Table 1). 
TLRs shown to be key players in triggering immunity against M.tb infection are TLR2 (alone 
or as a heterodimer with TLR1 or TLR6), TLR9, and probably TLR4 (Harding & Boom, 2010). 
TLR2 alone or dimerized with TLR1 or TLR6, is shown to trigger a strong pro-inflammatory 
response by recognizing  M.tb 19 KDa lipoglycoprotein, lower- and higher-order PIMs, LM 
and TDM [reviewed in (Jo et al., 2007)]. This pro-inflammatory response via TLR2 is shown 
to be mediated through its adaptor protein myeloid differentiation primary-response 
protein 88 (MyD88)(Quesniaux et al., 2004), triggering a nuclear factor kappa-light chain-
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enhancer of activated B cell (NFB) signaling cascade through the recruitment of MyD88 
and TIRAP (toll-interleukin 1 receptor [TIR] domain containing adaptor protein) (Kawai & 
Akira, 2010). Of no surprise the intensity of the immune response observed via TLR2 
depends on the M.tb ligand and the nature of the host cell studied (Thoma-Uszynski et al., 
2001;Underhill et al., 1999). Surprisingly, prolonged TLR2 signaling can also benefit M.tb. 
Studies implicating a prolonged stimulation of TLR2 showed an inhibition of antigen 
presentation due to the down-regulation in the expression of the major histocompatibility 
complex (MHC) class II in macrophages infected with M.tb (Harding & Boom, 2010). Other 
studies also show that M.tb is capable of inhibit MHC-I antigen cross processing and 
presentation to CD8+ T cells via TLR2 signaling (Harding & Boom, 2010). TLR2-dependent 
inhibition of TLR9-dependent IFN-/ expression, thus leading to a decrease of IFN-/-
dependent MHC-I cross processing is also shown in DCs (Simmons et al., 2010). In this 
regard, it is unknown if these described mechanisms of MHC-I and -II inhibition via TLR2 
will be beneficial for M.tb by passing the host immune response, or will be beneficial for the 
host by limiting the harmful effects of excessive inflammation. Thus, it is not unreasonable 
to search for a regulatory mechanism(s) among TLRs signaling networks necessary to 
control inflammation during M.tb chronic infection (Drennan et al., 2004;Simmons et al., 
2010). TLR9 recognizes unmethylated CpG (cytosine phosphate guanosine motif) found in 
M.tb DNA (Kawai & Akira, 2010). Activation of TLR9 induces IFN/and MHC-I antigen 
cross processing (Simmons et al., 2010). The role of TLR4 in M.tb infection is unclear as only 
a few M.tb ligands for TLR4 have been described.  Recently, recombinant M.tb heat shock 
protein (hsp) 65 was shown to induce the generation of TLR4-dependent NFB via MyD88-, 
TIRAP-, TRIF- (TIR-domain-containing adapter-inducing interferon-ǃ) and TRAM- (TRIF-
related adaptor molecule)-dependent signaling pathways (Bulut et al., 2005).  
3.2.2 Cytosolic receptor: NOD2 
Cytosolic regulators known as NODs receptors (Franchi et al., 2008) are known to participate 
in the induction of pro-inflammation during M.tb infection. Specifically Nod2, which is 
found in epithelial cells and antigen presenting cells (Gutierrez et al., 2002;Inohara and 
Nunez, 2003;Ogura et al., 2001), is shown to regulate the production of inflammatory 
mediators in response to M.tb PG components such as muramyl dipeptide  (MDP) (Brooks et 
al., 2011;Franchi et al., 2008;Sirard et al., 2007) (Table 1). Nod2 polymorphism studies in 
humans are linked to susceptibility to mycobacterial infection (Austin et al., 2008;F.R. Zhang 
et al., 2009). Studies done in vitro using different models and in vivo using the mouse model 
dispute the significance of Nod2 in controlling M.tb growth during infection (Divangahi et 
al., 2008;Gandotra et al., 2007). However, recent studies using human macrophages align 
with the human polymorphism studies showing that Nod2 plays a role in controlling pro-
inflammation and M.tb intracellular growth (Brooks et al., 2011). How Nod2 intersects with 
signaling/trafficking networks starts to be uncovered (Pandey et al., 2009). Although, Nod2 
can synergize with TLR-signaling pathways enhancing pro-inflammation (Ferwerda et al., 
2005), its capacity to interfere/associate with phagocytic receptor trafficking networks is not 
well established. As cytosolic Nod2 appears to be associated with intracellular vesicles 
(Brooks et al., 2011), its role in triggering pro-inflammation may depend on vesicular fusion 
events controlled during M.tb phagocytosis and phagosomal maturation (Sasindran & 
Torrelles, 2011). 
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3.3 Other phagocyte receptors 
Collectins such as surfactant protein –A and –D, and mannose binding protein, and their 
specific receptors have been shown to be important in M.tb recognition by the host; and 
their contribution in M.tb pathogenesis is discussed elsewhere (Sasindran & Torrelles, 
2011;Torrelles & Schlesinger, 2010;Torrelles et al., 2008a). Other receptors involved in the 
recognition of M.tb and inflammation are CD14, scavenger receptor-A, Fc-receptor, Mincle, 
and Dectin-1 (Sasindran & Torrelles, 2011). CD14 (Khanna et al., 1996) and the scavenger 
receptor SR-A (Zimmerli et al., 1996), are shown to participate in the uptake of non-
opsonized bacilli by tissue-specific macrophages; where their role in inflammation varies 
depending on the species-specific cell type used. Dectin-1 (dendritic cell-associated C-type 
lectin 1), a -glucan receptor, in combination with TLR2 has also been shown involved in the 
immune response against M.tb (Yadav & Schorey, 2006). Recently, Mincle (macrophage-
inducible C-type lectin) (Yamasaki et al., 2008) on the macrophage surface, has been shown 
to specifically recognize M.tb TDM, inducing a pro-inflammatory response by working 
together with the Fc receptor transmembrane segment (Ishikawa et al., 2009;Schoenen et al., 
2010)(Table 1). Conversely, Fc receptors do not play a role in the phagocytosis of M.tb in the 
absence of specific antibody (Schlesinger et al., 1990).  
In this type of studies we should carefully consider differences between model systems 
used. There are multiple examples of contradictions when comparing studies performed in 
vivo vs. in vitro and/or when comparing cells from an animal model vs. human primary 
cells. In this context, it is plausible that depending of the model used (i.e. primary alveolar 
macrophage vs. THP-1 cell; or human vs. another mammalian host cell), a host cell may 
differentially express the targeted receptor on its surface, or this targeted receptor may be 
involved in triggering additional or different signaling and/or trafficking network(s). The 
same concept can be attributed when studying different strains of M.tb. A clear example is 
the variable degree of mannosylation observed on the M.tb surface among different strains 
(i.e. less ManLAM and PIMs and more triglycerides, PGL-TB and PDIM on the cell wall of 
M.tb clinical isolates vs. M.tb laboratory strains H37Rv and Erdman) (Torrelles et al., 2008b), 
and how this may impact the infection outcome (Torrelles  & Schlesinger, 2010). In light of 
these findings, we need to be careful in considering which cell wall components are heavily 
present on the surface of the M.tb strain(s) studied and their implications in the host cell 
phenotype observed.   
4. M. tuberculosis-Host relationship with the alveolar environment(s) found 
during infection 
It is thought that initial interaction between M.tb and the host dictates the pathway and 
outcome of infection. When M.tb infection occurs by airborne transmission, bacilli are 
deposited in the alveolar spaces of the lungs. The traditional view is that M.tb is somewhat 
“static” during initial infection, does not induce an immune response, and it is taken up by 
non-activated AMs that serve as an important reservoir for infection. However, we envision 
that upon deposition in the alveolar space M.tb may enter a dynamic phase where it 
encounters pulmonary surfactant that contains homeostatic and antimicrobial enzymes 
(Hawgood & Poulain, 2001;van Golde, 1985) (called hydrolases) which alter the M.tb cell 
wall. Due to the dynamics of M.tb infection (Chroneos et al., 2009), when M.tb is initially 
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deposited in the terminal bronchioles and alveoli, as well as, following release from lysed 
macrophages and in cavities in reactivated TB, M.tb bacilli are in intimate contact with lung 
surfactant hydrolases. We recently demonstrated that hydrolases present in the human lung 
surfactant (Mason, 2006;Williams, 2003), at their relevant concentrations in vivo, dramatically 
alter the cell wall of M.tb during infection (Arcos et al., 2011). As a result of these cell wall 
modifications, a significant decrease in association of M.tb with human macrophages was 
observed followed by an increase in phagosome-lysosome fusion (35%), which translated to 
a significant decrease in M.tb intracellular survival within these cells and an increase in 
inflammatory cytokine production leading to better control of infection (Arcos et al., 2011).  
Importantly, we demonstrated that minimal contact time (15 min) with human lung 
surfactant hydrolases significantly reduced the cell surface exposure of two major M.tb 
virulence factors, ManLAM and TDM (Arcos et al., 2011). As mentioned above, both, 
ManLAM and TDM have been shown to play important roles in the intracellular survival of 
M.tb in the host by blocking the phagosome maturation process (Axelrod et al., 2008;Kang et 
al., 2005). Thus, below we will address which are the sources of these hydrolases in the 
alveolar space.  
4.1 The M. tuberculosis infection pathway and the alveolar environment: The potential 
role of human lung surfactant hydrolases 
The first interaction between M.tb and the human host takes place in the lung. The 
respiratory epithelium is actively involved in inflammation and host defense in multiple 
ways: providing a physical barrier, constituting the structural basis of mucociliary clearance 
aimed at the physical removal of inhaled bacteria; recognizing PAMPs/MAMPs by PPRs 
expressed on epithelial and myeloid cells, and secreting a variety of pro- and anti-
inflammatory mediators, including a large variety of hydrolases (Nicod, 2005). When M.tb 
bacilli reach the alveolar space, AMs, monocytes, and neutrophils represent the array of 
innate immune myeloid cells that will participate in host defense. 
4.1.1 The alveolar macrophage 
The AM is the first professional phagocyte to encounter inhaled M.tb bacilli. AMs are placed 
in a unique location within the alveolar surfactant film, the latter of which is produced by 
type II alveolar epithelial cells and is composed of phospholipids and proteins (Jonsson et 
al., 1986). AMs are at the interface between air and lung tissue, and represent the first line of 
defense against inhaled M.tb found in the air (Lohmann-Matthes et al., 1994). AMs possess a 
high phagocytic and clearance potential. In a normal healthy individual, they represent 
more than 90% of the cells in bronchoalveolar lavage fluid (Reynolds, 1987).  
Many studies have demonstrated that resident AMs can phagocytose large numbers of 
microbes through both opsonic and non-opsonic receptors (Fels & Cohn, 1986;Lohmann-
Matthes et al., 1994;Palecanda & Kobzik, 2001;Serrano-Gomez et al., 2004;Stephenson and 
Shepherd, 1987;Tailleux et al., 2005;Taylor et al., 2002;F.X. Zhang et al., 1999). Though AMs 
have high phagocytic activity, their microbicidal capacity is less well-defined. Efficient 
microbial phagocytosis followed by slow intracellular killing may be sufficient to control 
infection with many routinely encountered extracellular pathogens. Intracellular pathogens 
like M.tb, however, may take advantage of the reduced microbial activity of the AM by 
residing and multiplying within these cells (Ferguson & Schlesinger, 2000). The 
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participation of AMs in host defense, inflammatory processes and immune mechanisms has 
been amply documented (Schlesinger, 1997). In general, their primary function is the 
intracellular breakdown and disposal of particulate elements. In this regard, they contain a 
wide variety of hydrolases such as abundant lipase, acid phosphatase, cathepsin, lysozyme, 
esterase, acid ribonuclease, and -glucuronidase activities [on a specific activity basis] (Cohn 
& Wiener, 1963;Sorber et al., 1973). Interestingly, dead BCG-stimulated AMs exhibited up to 
a 4-fold increase in the activities for lipases, acid phosphatases and lysozyme compared to 
control (Cohn & Wiener, 1963) indicating an up-regulation of these hydrolases within the 
AMs in the presence of antigen. This observation was corroborated in AMs obtained from 
live BCG-vaccinated rabbits, where acid phosphatase, lipase and lysozyme activities 
increased up to 40-fold when compared to AMs from control rabbits (Sorber et al., 1973). 
How these hydrolases are regulated during M.tb infection and their role in redecorating the 
cell envelope of M.tb are currently unknown. 
4.1.2 Monocytes and neutrophils in the alveolar space 
Mononuclear phagocytes enter the lung both constitutively to maintain AM and dendritic 
cell populations, and during lung inflammation (Srivastava et al., 2005). The role of 
monocyte accumulation in the lung in acute and chronic pulmonary inflammation is largely 
unknown, although these cells are accessible by bronchoaleolar lavage (Maus et al., 2001). In 
the mouse, alveolar deposition of a stimulus provoked a significant influx of monocytes into 
the interstitium of the alveolar compartment along with a characteristic recruitment of 
neutrophils (Gunn et al., 1997;Li et al., 1998;Ulich et al., 1991). This was confirmed by studies 
showing that circulating leukocytes could be recruited across the endothelial and epithelial 
barriers into the alveolar space under both non-inflammatory and highly inflammatory 
conditions (Li et al., 1998;Maus et al., 2001). Given the capacity of monocytes to produce 
hydrolases, reactive oxygen species, or inflammatory cytokines (Van Furth, 1988), their 
accumulation has been implicated in several inflammatory diseases in the pulmonary 
system (Antoniades et al., 1992). As is the case for AMs, how monocytes and their secreted 
products affect the cell wall of M.tb within the alveolar space remains unknown. 
Neutrophils may play an important role in controlling M.tb infection (Pedrosa et al., 2000;Seiler 
et al., 2003). In the bronchoalveolar lavage fluid, they normally represent less than 2% of all 
cells, however, during inflammation a massive influx of neutrophils occurs (Mizgerd, 2002;P. 
Zhang et al., 2000). Neutrophils eliminate microbes by a number of oxidative and non-
oxidative mechanisms (P. Zhang et al., 2000) including secreted hydrolases such as N-acetyl--
glucosaminidase, -glucuronidase, -mannosidases, and lysozyme. Neutrophils can kill M.tb 
through both oxidative and non-oxidative processes (Brown et al., 1987;Jones et al., 1990). 
Although neutrophils may interact with M.tb cell wall components during alveolar deposition 
[such as the 19-KDa lipoglycoprotein, SL-1 and PGLs (Faldt et al., 1999;Neufert et al., 2001;L. 
Zhang et al., 1991)], there is no information regarding how alveolar neutrophil-derived 
hydrolases affect the integrity of the cell wall of M.tb during infection. 
4.1.3 Alveolar epithelial cells 
Alveolar epithelium lines the alveoli air sacs of the lung and is comprised predominantly of 
two specialized cell types (type I and type II). Alveolar type I cells function in gas exchange.  
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These cells have an extremely thin cytoplasm extending away from the nuclear body and 
contain a large number of plasmalemmal invaginations termed caveolae (Gil et al., 1981; 
Williams, 2003). Caveolae regulate removal of endogenous and exogenous particulates from 
the alveolar space by regulating activities of receptors, hydrolase secretion to the alveolar 
lumen and signaling molecules (Gumbleton, 2001;Marx, 2001;Razani & Lisanti, 2001). 
Importantly, these caveolae contain lipid phosphate phosphohydrolase, a critical enzyme in 
hydrolyzing a variety of phospholipids to produce diacylglycerol (Nanjundan & Possmayer, 
2003). Type I cells (as well as AMs) also produce carboxypeptidase which increases during 
bacterial deposition in the alveolar space and functions in the processing of many peptides 
(Skidgel & Erdos, 1998).  Other epithelial cell enzymes are related to the regulation of ion 
transport to the alveolar space (Johnson et al., 2002).  
Alveolar type II cells are considerably smaller than the type I cells and are richly endowed 
with organelles and microvilli on their apical membrane. These cells are located in the 
corners of the alveolus where their physiological functions include surfactant production, 
secretion and recycling (Fehrenbach, 2001). Surfactant is released to the alveolar space by 
exocytosis from intracellular storage organelles termed lamellar bodies which contain the 
majority of the components of the surfactant. During active secretion of contents from the 
lamellar bodies to the alveoli and during the surfactant recycling process, a variety of 
hydrolases have been related to these organelles (de Vries et al., 1985; DiAugustine, 1974; 
Edelson et al., 1988; Gilder et al., 1981; Hook & Gilmore, 1982; S.L. Young et al., 1993), many 
of which have lysosomal-type degradative functions. The presence of hydrolases within the 
lamellar bodies implies that if the contents of these structures are secreted, then hydrolases 
should also be secreted with surfactant. It has been shown that surfactant contains 
substantial quantities of hydrolases (Hook, 1978), where some hydrolases are highly active 
(i.e. -mannosidase and -N-acetylglucosaminidase) while others much less so (i.e. -
glucuronidase and arylsulfatase). Thus, the lamellar bodies provide a vehicle for the release 
of hydrolases into the alveoli, and their influence on host defense is being to be elucidated 
by our laboratory. In general, studies on epithelial cells have focused on phospholipases as 
second messengers in signaling, however, these same phospholipases are also degradative 
hydrolases with great potential to redecorate any microbial cell wall. For example, 
phospholipase A2 can release the fatty acids from phospholipids (Dennis, 2000). The action 
of phophatidylinositol phospholipase C provides both diacylglycerol and inositol 
trisphosphate. Other hydrolases include secreted and extracellular membrane-associated 
phosphatidic acid phosphatases which act on 1,2-diacyl,sn-glycerol phosphate to produce 
diacylglycerol and inorganic phosphate (Brindley & Waggoner, 1998), however, the 
membrane-associated hydrolases also act on a variety of phospholipids to generate anionic 
and/or neutral lipids (Nanjundan & Possmayer, 2003). These hydrolases may also be active 
against the rich phospholipid content of the cell wall of M.tb. (i.e. PIMs, cardiolipid, 
phosphatidylethanolamine, etc.) (Arcos et al., 2011). To what extent M.tb bacilli directly 
interact with epithelial cells and their secreted products remains unknown. However, the 
location of the alveolar epithelium, as well as, the relatively large alveolar epithelial surface 
area estimated at 100 to 140 m2, makes it likely that M.tb will interact with components of 
the alveolar space prior to and following its residence in the AM. The low alveolar fluid 
volume relative to the alveolar epithelial surface area (7- 20 ml per 100 m2) likely increases 
the local concentration of released hydrolases when compared to other tissue compartments. 
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This, in turn, increases the probability that secreted hydrolases will impact the M.tb bacillus 
in the alveoli, altering its cell envelope and metabolism. 
4.1.4 Pulmonary surfactant 
Pulmonary surfactant prevents alveoli from collapsing at low lung volumes by reducing the 
surface tension in the alveolar space. Dipalmitoylphosphatidylcholine comprises almost 
50% of total surfactant and is its major surface-active component (van Golde, 1985). The 
exact function of the remaining lipid components, such as unsaturated phosphatidyl-
cholines, phosphatidylglycerols, phosphatidylethanolamines, phosphatidyl-inositols, and 
cholesterol are still uncertain (King, 1982;van Golde, 1985). The surfactant protein fraction 
comprises a highly variable amount of serum proteins, a wide variety of specific hydrolases 
(Griese, 1999) and four apoproteins (the surfactant proteins termed SP-A, -B, -C, and –D) 
that contribute to its specific function (Weaver & Whitsett, 1991). As mentioned above, 
surfactant contains several products secreted by alveolar myeloid and epithelial cells, some 
of them already defined in host defense, such as the bacteriolytic lysozyme (Haller et al., 
1992;Singh et al., 1988). The wide variety of hydrolases secreted into surfactant resemble but 
are distinct from lysosomal enzymes (Hook and Gilmore, 1982). The surfactant resident 
hydrolases alter the M.tb cell wall (Arcos et al., 2011). 
There remain many fundamental questions about how the alveolar environment influences 
M.tb pathogenesis. We recently showed that secreted hydrolases involved in surfactant 
homeostasis affect the M.tb cell wall (Arcos et al., 2011) and/or trigger M.tb endogenous 
hydrolases to modify its own cell wall prior to contacting its natural niche, the AM, or after 
its lysis from the cell. Exposure of ‘de novo’ motifs on the surface of M.tb after alveolar 
enzymatic processing will provide insight into the real nature of the M.tb cell envelope 
during infection. Since components of the M.tb cell envelope dictate the innate immune 
response against the bacillus via their interaction with surface receptors on myeloid cells, 
the identification of hydrolases that shape the surface of the M.tb cell envelope will enable 
more predictive in vitro models to be developed and novel drug targets to be identified.  
5. Conclusions 
The interface between M.tb and the host depends of many factors. M.tb strains differ in their 
cell wall components exposed on their surface. Even within the same strain, it is likely that 
some bacilli differ, and thus bacilli may interact different with the host. Thus, at a given 
infection we may find a mixture of events. On one hand, and depending on the cell wall 
components exposed on their surface, we may find bacilli that interact with a receptor 
inducing pro-inflammation and promoting M.tb killing, and on the other hand, we may find 
bacilli interacting with another receptor inducing anti-inflammation and M.tb intracellular 
survival. From the host perspective, genetic predisposition and living conditions dictate the 
predilection for M.tb infection. Even in the context of the same infected person and within 
the same host cell population, differences amongst cells in the expression of cell surface 
receptors, signaling, trafficking and innate and adaptive function exist. These differences in 
the host get enhanced even more when we compare host cells from different model systems. 
Our current studies on the impact of the alveolar space in the M.tb infection outcome also 
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indicate that environmental host factors, such as alveolar hydrolases, play important roles in 
the establishment of the infection. With this in mind, what are the necessary elements that 
result in a succesful M.tb infection? Is M.tb infection just chance or a perfect combination of 
bacterial and host elements? Upon the successful establishment of M.tb infection, the 
ultimate goal of the host is to reduce inflammation and tissue destruction and in this 
scenario M.tb has learned to evolve, adapt, and survive.  
What do we know about the M.tb cell wall adaptation to the host? The most revealing 
attribute of the M.tb cell wall is its complexity. Studies have been focused on depicting the 
composition, structure, biosynthesis, and the spatial conformation of the M.tb cell wall 
and its components for decades. Currently, researchers are focusing to reveal how the cell 
wall of M.tb is during infection (in vivo and in vitro). The development of new 
technologies and/or the use of known technologies already successfully applied in other 
fields (such as cancer research) are moving fast into the field of TB. Thus, studies using 
scanning electron and atomic force microscopy revealed that the M.tb cell wall from MDR- 
and XDR-strains differs from susceptible strains (Velayati et al., 2009a, 2009b, 2010). 
Experiments analyzing infected granulomas by using high-resolution magic angle 
spinning nuclear magnetic resonance (HR-MAS-NMR) showed that we are capable of 
analyzing the cell wall of M.tb when inside of the granuloma without further 
manipulation (Somashekar et al., 2011). The introduction of novel reporters that can be 
used for selective labeling of the cell wall of M.tb during infection in vitro and in vivo is 
already allowing us to see how the cell wall of M.tb is remodeling during infection 
(Backus et al., 2011). Efforts in improving purification techniques are also allowing us to 
be able to purify M.tb directly from infected tissues. The use of novel state-of-the art mass 
spectrometry techniques such as LC/MS/MS (Sartain et al., 2006, 2011), ESI/MS (Barry et 
al., 2011) and MALDI-Tissue Imaging (Prideaux et al., 2011) in drug discovery will allow 
us to obtain new information about the cell wall composition from a single M.tb bacillus 
isolated from tissue and also to see how M.tb cell wall components, and other biomarkers 
and drugs are distributed within the infected tissue. These are few of many other novel 
biotechniques that are starting to be applied in the field of TB. But this is only the 
beginning, more efforts improving the protocols and the development of new technology 
will allow us to move quickly to solve the “mystery” involving how M.tb adapted to the 
host and became such a successful infection currently affecting one third of the world 
population and taking away ~2 million lives every year. 
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